Innoviva
INVA
$12.90
Share price
-0.23%
Change (1 day)
-9.47%
Change (1 year)
Categories
EPS for Innoviva (INVA)
EPS in 2023 (TTM): $3.36
According to Innoviva's latest financial reports the company's current EPS (TTM) is $3.36. In 2022 the company made an earnings per share (EPS) of $3.07 a decrease over its 2021 EPS that were of $3.13.
EPS history for Innoviva from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.36 | 9.45% |
| 2022 | $3.07 | -1.92% |
| 2021 | $3.13 | 40.99% |
| 2020 | $2.22 | 44.16% |
| 2019 | $1.54 | -60.61% |
| 2018 | $3.91 | 210.32% |
| 2017 | $1.26 | 129.09% |
| 2016 | $0.55 | -443.75% |
| 2015 | -$0.16 | -89.4% |
| 2014 | -$1.51 | -9.58% |
| 2013 | -$1.67 | 1291.67% |
| 2012 | -$0.12 | -91.49% |
| 2011 | -$1.41 | 20.51% |
| 2010 | -$1.17 | -13.97% |
| 2009 | -$1.36 | -11.11% |
| 2008 | -$1.53 | -42.05% |
| 2007 | -$2.64 | -6.38% |
| 2006 | -$2.82 | 4.83% |
| 2005 | -$2.69 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -108.04% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -129.76% | 🇺🇸 USA |